Bibliografisk note

Funding Information:
This work was supported by the Wellcome Trust (Grant No. 106047 [to JM]), S?r Cymru II COFUND Fellowship from the Welsh Government (to JM), National Institutes of Health (Grant No. 5U01MH109539 [to RKW], Grant Nos. R01NS102371-01A1, R01MH113362, U01HG009086, R01MH118223, and RM1HG009034 [to LKD], Grant No. R01CA229618 [to BES], Grant Nos. R00MH101367 and R01MH119243 [to PHL], and Grant No. MH109532 [to HJE]), Stanley Center for Psychiatric Research (to RKW), National Institute for Health Research (NIHR) as part of the Maudsley Biomedical Research Centre (to JRIC and GB), European Union Horizon 2020 Programme for research and innovation (H2020/2014-2020) (Grant No. 667302 [CoCA] [to ADB], Grant Nos. 667302 and 728018 [to SVF], and Grant No. 847879 [PRIME] [to JB]), European Union Seventh Framework Programme for research, technological development and demonstration (Grant No. 602805 [to SVF]), National Institute of Mental Health (Grant Nos. 5R01MH101519 and U01 MH109536-01 [to SVF], Grant No. K01MH113848 [to REP], and Grant No. R01MH114924 [to LAW and MT]), Brain & Behavior Research Foundation (Grant No. 28632 P&S Fund [to REP]), and National Institute of Neurological Disorders and Stroke (Grant Nos. R01 NS102371 and R01 NS105746 [to CAM]). High-performance computing facilities were funded with capital equipment grants from the Guy's and St. Thomas? Charity (Grant No. TR130505) and Maudsley Charity (Grant No. 980). The iPSYCH team was supported by the Lundbeck Foundation (Grant Nos. R165-2013-15320, R102-A9118, R155-2014-1724, and R248-2017-2003) and the universities and university hospitals of Aarhus and Copenhagen. The Danish National Biobank resource was supported by the Novo Nordisk Foundation. Data handling and analysis at GenomeDK were supported by the National Institute of Mental Health (Grant No. 1U01MH109514-01 [to ADB]). High-performance computer capacity for handling and statistical analysis of iPSYCH data at GenomeDK was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to ADB). This work utilized the computational resources of the Dutch national e-infrastructure with the support of SURF Cooperative (https://userinfo.surfsara.nl/). The original GWAS data were supported by National Institute of Mental Health Psychiatric Genomics Consortium (PGC) grants (Grant Nos. U01 MH109528, U01 MH109539, U01 MH109536, U01 MH109501, U01 MH109514, U01 MH109499, and U01 MH109532). This study represents independent research partly funded by the NIHR Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care. The other members of the Sex Differences Cross-Disorder Analysis Group of the PGC are Martin Alda, Marco Bortolato, Christie L. Burton, Enda Byrne, Caitlin E. Carey, Lauren Erdman, Laura M. Huckins, Manuel Mattheisen, Elise Robinson, and Eli Stahl. JM and EAK were responsible for study conception, design, analyses, and writing. SBG and GAMB were responsible for analyses and writing. MT, RKW, CH, JRIC, and GB were responsible for analyses and editing. ADB, DD, JG, TW, JB, CMB, PHL, CAM, REP, SJW, NW, HJE, WG, YY, BMN, SVF, TLP, LAW, and LED were responsible for editing. JMG and JWS were responsible for writing. BES and LKD were responsible for writing and analytic supervision. We thank Dr. Helena Gaspar for providing a python script that was used to estimate differences in linkage disequilibrium score regression genetic correlation across sex and Donald Hucks for computing population prevalence by sex for the BioVU (Vanderbilt University Medical Center biobank) population. We also thank the following consortia and groups that contributed data: Attention Deficit Hyperactivity Disorder Working Group of the PGC and iPSYCH, Autism Spectrum Disorder Working Group of the PGC and iPSYCH, Bipolar Disorder Working Group of the PGC, Major Depressive Disorder Working Group of the PGC, Obsessive Compulsive Disorder Working Group of the PGC, Post-traumatic Stress Disorder Working Group of the PGC, Schizophrenia Working Group of the PGC, Substance Use Disorders Working Group of the PGC, and UK Biobank GWAS results generated by the Neale Lab (http://www.nealelab.is/uk-biobank/). CMB has received a grant from and is a Scientific Advisory Board member of Shire, is a consultant for Idorsia Pharmaceuticals, and has received author royalties from Pearson. EAK is employed by Janssen Pharmaceutical Companies of Johnson & Johnson. All other authors report no biomedical financial interests or potential conflicts of interest.

Funding Information:
This work was supported by the Wellcome Trust (Grant No. 106047 [to JM]), Sêr Cymru II COFUND Fellowship from the Welsh Government (to JM), National Institutes of Health (Grant No. 5U01MH109539 [to RKW], Grant Nos. R01NS102371-01A1 , R01MH113362 , U01HG009086 , R01MH118223 , and RM1HG009034 [to LKD], Grant No. R01CA229618 [to BES], Grant Nos. R00MH101367 and R01MH119243 [to PHL], and Grant No. MH109532 [to HJE]), Stanley Center for Psychiatric Research (to RKW), National Institute for Health Research (NIHR) as part of the Maudsley Biomedical Research Centre (to JRIC and GB), European Union Horizon 2020 Programme for research and innovation (H2020/2014-2020) (Grant No. 667302 [CoCA] [to ADB], Grant Nos. 667302 and 728018 [to SVF], and Grant No. 847879 [PRIME] [to JB]), European Union Seventh Framework Programme for research, technological development and demonstration (Grant No. 602805 [to SVF]), National Institute of Mental Health (Grant Nos. 5R01MH101519 and U01 MH109536-01 [to SVF], Grant No. K01MH113848 [to REP], and Grant No. R01MH114924 [to LAW and MT]), Brain & Behavior Research Foundation (Grant No. 28632 P&S Fund [to REP]), and National Institute of Neurological Disorders and Stroke (Grant Nos. R01 NS102371 and R01 NS105746 [to CAM]).

Funding Information:
The iPSYCH team was supported by the Lundbeck Foundation (Grant Nos. R165-2013-15320, R102-A9118, R155-2014-1724, and R248-2017-2003) and the universities and university hospitals of Aarhus and Copenhagen. The Danish National Biobank resource was supported by the Novo Nordisk Foundation. Data handling and analysis at GenomeDK were supported by the National Institute of Mental Health (Grant No. 1U01MH109514-01 [to ADB]). High-performance computer capacity for handling and statistical analysis of iPSYCH data at GenomeDK was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to ADB).

Funding Information:
This study represents independent research partly funded by the NIHR Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care.

Funding Information:
High-performance computing facilities were funded with capital equipment grants from the Guy’s and St. Thomas’ Charity (Grant No. TR130505) and Maudsley Charity (Grant No. 980).

Funding Information:
The original GWAS data were supported by National Institute of Mental Health Psychiatric Genomics Consortium (PGC) grants (Grant Nos. U01 MH109528, U01 MH109539, U01 MH109536, U01 MH109501, U01 MH109514, U01 MH109499, and U01 MH109532).

Publisher Copyright:
© 2021 Society of Biological Psychiatry